Sign In
Buy NVAX
$7.89
-0.0600 (-0.755%)
At Close: Aug 10, 2026
Novavax enters license agreement with Pfizer for vaccine development
07:11am, Tuesday, 20'th Jan 2026
Novavax said on Tuesday it was entering into a licensing agreement with Pfizer to develop vaccine products for infectious diseases.
Novavax, Inc. (NVAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
10:15pm, Wednesday, 14'th Jan 2026
Novavax, Inc. (NVAX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Why Novavax (NVAX) Dipped More Than Broader Market Today
06:46pm, Wednesday, 14'th Jan 2026
Novavax (NVAX) concluded the recent trading session at $8.19, signifying a -5.54% move from its prior day's close.
Novavax (NVAX) Moves 11.9% Higher: Will This Strength Last?
09:21am, Wednesday, 14'th Jan 2026
Novavax (NVAX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know
10:01am, Tuesday, 13'th Jan 2026
Novavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference
08:00am, Wednesday, 07'th Jan 2026
GAITHERSBURG, Md., Jan. 7, 2026 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the 44th Annual J.P.
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Tuesday, 30'th Dec 2025
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
10:01am, Friday, 19'th Dec 2025
Zacks.com users have recently been watching Novavax (NVAX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Why I Wouldn't Touch Novavax With a 10-Foot Pole
12:41pm, Thursday, 11'th Dec 2025
Novavax faces plenty of uncertainty related to a deal it signed with a larger company. The biotech's pipeline doesn't look that exciting either.
Here is What to Know Beyond Why Novavax, Inc. (NVAX) is a Trending Stock
10:01am, Monday, 08'th Dec 2025
Novavax (NVAX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Dow Jones Today: Stock Indexes Close Lower to Begin December Trading; Big Tech, Crypto-Tied Shares Drop Amid Risk-Off Sentiment
08:00pm, Monday, 01'st Dec 2025
Major stock indexes pulled back as the final trading month of the year began, with shares of big tech and cryptocurrency-tied firms falling amid risk-off sentiment.
FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks
03:50pm, Monday, 01'st Dec 2025
A report that vaccine approvals could be set to get stricter is pressuring shares of major vaccine makers.
Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men
12:35pm, Monday, 01'st Dec 2025
Memo also reportedly mentions vaccines for flu and pneumonia.
Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals
09:59am, Monday, 01'st Dec 2025
The FDA's top vaccine regulator outlines proposed changes to the vaccine evaluation process in an internal memo.
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?
10:01am, Tuesday, 25'th Nov 2025
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
